• 116. ASCO 2024 - Early Lung Cancer & Mesothelioma

  • Jun 14 2024
  • Length: 28 mins
  • Podcast

116. ASCO 2024 - Early Lung Cancer & Mesothelioma By cover art

116. ASCO 2024 - Early Lung Cancer & Mesothelioma

Listen for free

View show details

  • Summary

  • ASCO 2024 beat many attendees' expectations with interesting and thought-provoking lung cancer and mesothelioma studies. While not all of these will change the face of patient treatment, they will add to a body of evidence for biomarkers and build on the blocks of tailoring treatment to patients.


    Links to studies discussed in this episode (subscription may be required):

    BEAT-meso: Link

    Checkmate 816 4 year update: Link

    MIST5: Link

    ctDNA-Lung-DETECT: Link

    BEAT-SC: Link


    For more episodes, resources and blog posts, visit www.inquisitiveonc.com

    Please find us on Twitter @InquisitiveOnc!

    If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.com


    Oncology for the Inquisitive Mind is recorded with the support of education grants from Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have no editorial rights or early previews, and they have access to the episode at the same time you do.


    Art courtesy of Taryn Silver

    Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/


    Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.


    Hosted on Acast. See acast.com/privacy for more information.
    Show more Show less
activate_primeday_promo_in_buybox_DT
Physical Illness & Disease Hygiene & Healthy Living Biological Sciences
Show more Show less

What listeners say about 116. ASCO 2024 - Early Lung Cancer & Mesothelioma

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available